News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: June 1, 2023
“The study showed that Posluma PET provided clinically valuable information prior to surgery that would likely result in management changes for the...
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: May 19, 2023
Epcoritamab for adults with relapsed/refractory diffuse large B-cell lymphoma has been approved by the FDA.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: April 18, 2023
Stem cell therapy approved by FDA for blood cancer patients aged 12 and older is aimed at reducing the risk of infections.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: April 12, 2023
Many cancer therapies increase the risk of atrial fibrillation, but this is underreported in clinical trials.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: March 13, 2023
Study: Extent of skin erythema correlates with deaths from graft-versus-host disease in blood cancer patients after stem cell transplants.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: March 6, 2023
Nicotinamide (vitamin B3) has been shown to prevent nonmelanoma skin cancers in healthy, immunocompetent people, so physicians routinely prescribe ...
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: February 27, 2023
Recently published clinical data showed that a costly new gene therapy for hemophilia A was found largely durable at 2 years.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: February 17, 2023
Surgery and postoperative chemotherapy are standard of care for advanced gastric cancer, but up to half of patients develop peritoneal metastases w...
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: February 17, 2023
Trial randomly assigns 1,326 women who had undergone a lumpectomy to either whole-breast irradiation or no radiation on a background of&n...
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: February 15, 2023
“This is the first randomized study demonstrating the benefit of an alternate radiosensitizing agent in cisplatin-ineligible patients.”
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: February 15, 2023
Identifying predictors allows surgeons to send high-risk individuals for oncologic evaluation beforehand and to prepare for intraoperative frozen p...
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: February 10, 2023
Study authors suggest that 30 Gy in five daily fractions is a ‘valid option’ for patients who received lumpectomy for early breast cancer.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: February 6, 2023
Label expansion for the Trop-2–directed antibody-drug conjugate was based on the TROPICS-02 trial.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: February 2, 2023
The agency also approved the Guardant360 CDx assay as a companion diagnostic to identify breast cancer patients who meet the treatment requirements...
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: January 23, 2023
This is the first FDA-approved treatment for HER2-positive metastatic colorectal cancer.
